2024 Video Webinar Series

Drug Channel Implications of the Inflation Reduction Act (REPLAY)

Dr. Adam J. Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels, invites you to join him for DCI’s latest live video webinar:

Drug Channel Implications of the Inflation Reduction Act
This event was broadcast live on Friday, April 5, 2024.

This page describes the event and explains how to purchase a replay. Jump to pricing options. The webinar was broadcast from the Drug Channels studio in beautiful downtown Philadelphia.

This event is part of The Drug Channels 2024 Video Webinar Series.

WHAT YOU WILL LEARN

The Inflation Reduction Act of 2022 (IRA) has already begun to alter the Medicare Part D program and trigger changes in beneficiary out-of-pocket spending, drug prices, pharmacy economics, and market access strategies. The IRA’s impact will extend far beyond the Medicare program into many aspects of the overall drug channel.

In this all-new webinar, Dr. Fein unpacked the intended and unintended consequences of the IRA for the commercial market and drug channel participants, including:

  • What’s ahead for brand-name drug list and net prices
  • The coming battles over high-list/high-rebate products
  • The Medicare Advantage boom and the collapse of the stand-alone PDP market
  • The gross-to-net bubble outlook for Part D
  • The IRA’s spillover impact on the gross-to-net bubble in commercial markets
  • How the IRA will impact Medicaid rebates and change the 340B Drug Pricing Program
  • What’s ahead for utilization management
  • Retail pharmacies’ coming financial challenges
  • The uptick in consolidation of physician practices
  • Biosimilar market uncertainties
  • And much more!

PLUS: During the webinar, Dr. Fein gave participants an opportunity to unmute themselves and ask live questions. The webinar lasted over 90 minutes to accommodate audience questions.

As always, Dr. Fein clearly distinguished his opinions and interpretations from the objective facts and data. He also drew from exclusive information found in DCI’s new 2024 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers.

Please note that Dr. Fein focused on the IRA’s patient and commercial market impacts. The potential effect of the IRA on manufacturers’ new drug research and development strategies was beyond the scope of this webinar.

Read on for full details on pricing and registration.

PRICING OPTIONS

You can register to watch a replay of this unique educational opportunity for only $400 per viewing device. Within 24 hours of your purchase, you will receive an email from Zoom with a unique link to access the event.

We are offering substantial discounts for multiple registrations from the same organization. We know that many of you are now working remotely, so rates for multiple registrations are as low as $280 per device—a 30% savings. An unlimited number of people may watch at one physical location if they can watch from a single device. Please note that a device at a single physical location may not record, stream, share, or project our webinar to other sites. Each device at a physical location requires its own registration.

Click here to order. All discounts will be automatically computed based on the number of registrations you enter in your cart. (You can reset the cart by entering 0 in the quantity field.)

Drug Channel Implications of the Inflation Reduction Act (REPLAY) ORDER

(You can reset the cart by entering 0 in the quantity field.)

Please contact Paula Fein (paula@drugchannels.net) if you have any questions. If you purchase access for multiple devices, we will contact you for a list of your participants and their email addresses. Or, download this spreadsheet and email your registrants’ information to admin@drugchannels.net.

Payment can be made with all major credit cards (Visa, MasterCard, American Express, and Discover) or via PayPal. Click here to email us if you would like to pay by corporate purchase order or check.

IMPORTANT THINGS TO KNOW

  • Watch and listen via any device with a web browser (computer, iPad, iPhone/Android, etc.) There is no access via telephone.
  • We used Zoom technology for this webinar. Every registrant will receive an email from Zoom with a link to watch the event. This link is unique to the registrant and can only be accessed once. We recommend that every registrant download the Zoom client software/app.
  • Every registrant will receive an email from Zoom with links to download Dr. Fein’s slides.
  • Organizations that purchased corporate access for The Drug Channels 2024 Video Webinar Series received a custom, branded signup link so employees can easily register. We will automatically refund payments from anyone at a company with corporate access who purchases a single registration using their corporate email account.
  • Each registration for a DCI webinar is valid for a single device at a single physical location. Each device at a physical location requires its own registration. Attendees are not permitted to record, stream, share, or project a DCI webinar to other sites or locations. Purchasers who violate this limitation by recording, streaming, sharing, or projecting a DCI webinar to other sites or locations are liable for the full cost of all locations that viewed the webinar. DCI reserves the right to prohibit purchasers who violate our terms from attending future DCI webinars.
  • Unfortunately, we are unable to offer refunds.